Current filters:  
Life Sciences, Biotechnology & Nanotechnology
Preslmayr Rechtsanwälte OG
The financing of the Austrian healthcare system by the social security institutions differs between the inpatient and the outpatient sector:
Siskinds LLP
The Not For Resale ("NFR") distribution entry model to the Canadian market is acutely misunderstood. This discussion will outline the top 3 NFR "myths", and explore potential legal risks...
Blake, Cassels & Graydon LLP
Canada has a vibrant life sciences and pharmaceutical industry, with a broad array of firms conducting research and developing innovative medicines, generic medicines, biosimilar products...
Smart & Biggar
On June 4, 2020 the Federal Court dismissed an application for judicial review brought by Canada RNA Biochemical Inc of Health Canada's refusal of C-RNA's application for a natural health product...
Smart & Biggar
Further to our June 1, 2020 update, regulations amending the coming into force date of the Regulations Amending the Patented Medicines Regulations
Torys LLP
Over the last several years, there has been a great deal of uncertainty regarding Canada's patented drug pricing regime.
Blake, Cassels & Graydon LLP
COVID-19 is transforming the way businesses create products and go-to-market, especially when launching health products during a pandemic, on an expediated timeline.
Smart & Biggar
The PMPRB has just released revised draft Guidelines operationalizing the amended Patented Medicines Regulations, simultaneously beginning a 30-day consultation period.
Mayer Brown
On 30 April 2020, the National People's Congress of China (the "NPC") published the Biological Safety Law (Draft for Second Reading) (the "Draft Law") for public consultation until 13 June 20201.
Article 175 of the 2006 Health Law required medicines suppliers to exchange products that are about to expire in accordance with "… with what the corresponding regulation establishes."
El artículo 175 de la Ley Orgánica de Salud, del año 2006, dispuso a los proveedores de medicamentos la obligación de canjear aquellos productos que están próximos a caducar de conformidad "…con lo que establezca la regulación correspondiente"
European Union
Kilinc Law & Consulting
The Medical Device Directive ("MDD") of the European Council numbered 93/42/EEC, which came into force in 1993 and amended in 2007 with the Directive 2007/47 /EC...
Arnold & Porter
Although the date of application of the Medical Devices Regulation (MDR) has been delayed by a year, to May 2021, the EU institutions continue to work on its implementation to ensure that the new framework is workable...
Hong Kong
Mayer Brown
This Legal Update follows up on our previous Legal Update.
Khaitan & Co
In the matter of Genentech Inc and others v Drugs Controller General of India and others, CS(OS) 3284 of 2015 (Suit), the Learned Single Judge of the Delhi High Court (Court) has passed an order dated 2 March 2020 (decision)...
Yigal Arnon & Co
The corona epidemic requires the use of all the tools available to doctors in the fight, including digital medicine.
Caiado Guerreiro, Sociedade de Advogados
Ordinance No. 90-A/2020, of April 9, has just arrived and it brings about an exceptional and temporary regime for electronic prescription of medicines and respective medical prescriptions...
Caiado Guerreiro, Sociedade de Advogados
Following the declaration by the World Health Organization of a world health emergency due to the infection by SARS-CoV-2, the Portuguese Drug Agency (INFARMED) has published a set of exceptional measures ...
Caiado Guerreiro, Sociedade de Advogados
Decree-Law No. 14-E/2020, of April 13, establishes an exceptional and temporary regime for the design, manufacture, import, national commercialisation and use of medical devices for human use...
GRATA International
Производство медицинских изделий является ...
FREE News Alerts
Sign Up for our free News Alerts - All the latest articles on your chosen topics condensed into a free bi-weekly email.
Popular Contributors
Upcoming Events
Font Size:
Mondaq Social Media